Rheb Binds and Regulates the mTOR Kinase

@article{Long2005RhebBA,
  title={Rheb Binds and Regulates the mTOR Kinase},
  author={Samuel Long and Yenshou Lin and Sara Ortiz-Vega and Kazuyoshi Yonezawa and Joseph Avruch},
  journal={Current Biology},
  year={2005},
  volume={15},
  pages={702-713}
}

Figures from this paper

Evaluation of the Binding Kinetics of RHEB with mTORC1 by In-Cell and In Vitro Assays
TLDR
RHEB engages two different binding sites of mTOR, ∆N-FAT-M and ∆ATP, with higher affinity for ∆ ATP, which likely regulates the kinase activity of m TOR through multiple different biding modes.
Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency*
TLDR
The binding of Rheb to endogenous and recombinant mTOR is reversibly inhibited by withdrawal of all extracellular amino acids or just leucine, and the binding of mTOR to RheB mutants that are unable to bind guanyl nucleotide in vivo is also inhibited by amino withdrawal.
Small GTPases in C. elegans metabolism
TLDR
In this commentary, the advantages of studying the mTOR pathway in C. elegans are highlighted, including the subcellular localization of the signaling pathway components and the animal phenotypes following tissue specific protein over-expression or knockdown.
Re-evaluating the Roles of Proposed Modulators of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling*
TLDR
It is suggested that uncharged tRNALeu does not switch off mTORC1 signaling and suggest that m TORC1 is controlled by a distinct pathway that senses the availability of amino acids.
Activation of mTORC1 in two steps: Rheb-GTP activation of catalytic function and increased binding of substrates to raptor.
TLDR
The mechanism of insulin/nutrient stimulation of m TOR complex 1 signalling, in addition to Rheb-GTP activation of the mTOR catalytic function, also involves a stable modification of the configuration of mTORC1 (mTOR complex 1) that increases access of substrates to their binding site on the raptor polypeptide.
Amino acid regulation of TOR complex 1.
TLDR
This review focuses on the biochemical mechanisms that regulate m TORC1 kinase activity, with special emphasis on mTORC1 regulation by amino acids, and the rag GTPases, functioning as obligatory heterodimers.
Cryo-EM insight into the structure of MTOR complex 1 and its interactions with Rheb and substrates
TLDR
A deep understanding is sought of how MTORC1 interacts with and phosphorylates its best-known substrates—the eIF-4E binding protein/4E-BP, the p70 S6 kinase/S6K1B, and PRAS40/AKT1S1—and how this is inhibited by rapamycin.
MCRS1 binds and couples Rheb to amino acid-dependent mTORC1 activation.
Phospholipase D1 is an effector of Rheb in the mTOR pathway
TLDR
The findings reveal an unexpected interaction between two cascades in the mTOR signaling pathways and open up additional possibilities for targeting this important growth-regulating network for the development of anticancer drugs.
Activation of mTORC 1 in two steps : Rheb-GTP activation of catalytic function and increased binding of substrates to raptor 1
TLDR
The mechanism of insulin/nutrient stimulation of m TOR complex 1 signalling, in addition to Rheb-GTP activation of the mTOR catalytic function, also involves a stable modification of the configuration of mTORC1 (mTOR complex 1) that increases access of substrates to their binding site on the raptor polypeptide.
...
...

References

SHOWING 1-10 OF 93 REFERENCES
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.
TLDR
The data demonstrate that Rheb acts downstream of TSC1/TSC2 and upstream of mTOR to regulate cell growth and plays an essential role in regulation of S6K and 4EBP1 in response to nutrients and cellular energy status.
Rheb Binds Tuberous Sclerosis Complex 2 (TSC2) and Promotes S6 Kinase Activation in a Rapamycin- and Farnesylation-dependent Manner*
TLDR
The ability of Rheb to induce S6 phosphorylation was also inhibited by a farnesyl transferase inhibitor, suggesting that RheB may be responsible for the Ras-independent anti-neoplastic properties of this drug.
Regulation of eIF-4E BP1 Phosphorylation by mTOR*
TLDR
It is concluded that mTOR is an upstream regulator of eIF-4E BP1 as well as the p70 S6 kinase; moreover, these two mTOR targets are regulated in a parallel rather than sequential manner.
Rheb promotes cell growth as a component of the insulin/TOR signalling network
TLDR
Genetic and biochemical tests indicate that Rheb functions in the insulin signalling pathway downstream of Tsc1–Tsc2 and upstream of TOR, suggesting a role for rheb in the nutritional control of cell growth.
The Mammalian Target of Rapamycin (mTOR) Partner, Raptor, Binds the mTOR Substrates p70 S6 Kinase and 4E-BP1 through Their TOR Signaling (TOS) Motif*
TLDR
Raptor appears to serve as an mTOR scaffold protein, the binding of which to the TOS motif of mTOR substrates is necessary for effective mTOR-catalyzed phosphorylation in vivo and perhaps for conferring their sensitivity to rapamycin and amino acid sufficiency.
Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals
TLDR
It is demonstrated that Rheb interacts with and appears to regulate Raf-1 kinase, an essential component of the H-Ras signaling pathway, which is potentiated by growth factors in combination with agents that increase cyclic AMP levels.
Immunopurified Mammalian Target of Rapamycin Phosphorylates and Activates p70 S6 Kinase α in Vitro *
TLDR
Results indicate that mTOR is likely to function as a direct activator of p70 in vivo, although the relative contribution of mTOR-catalyzed p70 phosphorylation in each of the many circumstances that engender p70 activation remains to be defined.
...
...